Musk v. Altman week 1: Elon Musk says he was duped, warns AI could kill us all, and admits that xAI distills OpenAI’s models
OpenAI's governance and ownership structure remains contested in court — agencies relying on OpenAI-backed products should note the instability.
Key points
- Musk v. Altman trial began, centering on whether OpenAI's for-profit restructuring breached its founding mission.
- xAI's admission that it distils OpenAI models raises questions about competitive claims and IP boundaries in frontier AI.
- Limited direct APS relevance; useful background on OpenAI's governance instability ahead of a potential IPO.
Implications for Australian agencies
- Monitor Agencies or teams using OpenAI-backed products or evaluating vendors may want to monitor how the trial affects OpenAI's corporate and governance structure over coming months.
Implications are AI-generated. Starting points, not advice — see methodology for how they're framed.
View original source
Copied.
Appeared in:
Weekly digest, 27 April 2026
"Musk v. Altman week 1: Elon Musk says he was duped, warns AI could kill us all, and admits that xAI distills OpenAI’s models"
Source: MIT Technology Review – AI
Published: 1 May 2026
URL: https://www.technologyreview.com/2026/05/01/1136800/musk-v-altman-week-1-musk-says-he-was-duped-warns-ai-could-kill-us-all-and-admits-that-xai-distills-openais-models/
Week one of the Musk v. Altman civil trial saw Elon Musk testify that he was misled about OpenAI's commercial trajectory, having contributed $38 million expecting a nonprofit AI-safety organisation. Musk is seeking to remove Altman and Brockman and unwind OpenAI's for-profit restructuring, which underpins its path to an IPO at close to $1 trillion. OpenAI's counsel countered that Musk is motivated by competitive rivalry rather than safety principles, citing xAI's own lawsuit against a Colorado AI anti-discrimination law. The trial's outcome could materially affect OpenAI's corporate structure and IPO timeline.
Implications for Australian agencies:
- [Monitor] Agencies or teams using OpenAI-backed products or evaluating vendors may want to monitor how the trial affects OpenAI's corporate and governance structure over coming months.
Retrieved from SIMS, 18 July 2026.